» Articles » PMID: 28945652

Comparison Between Viscous Teardrops and Saline Solution to Fill Orthokeratology Contact Lenses Before Overnight Wear

Overview
Specialty Ophthalmology
Date 2017 Sep 26
PMID 28945652
Citations 7
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: To compare, in terms of efficacy, the differences between the use of saline solution and a viscous artificial tear to fill the lens during the first month of orthokeratology wear.

Methods: A pilot, double-masked, crossed, randomized, and prospective study was conducted. In this study, 20 subjects (14 males and 6 females) with a mean age of 16.29±6.22 years (range, 10-26) were fitted with orthokeratology contact lenses. For the study, nonpreserved 0.9% NaCl commercial saline solution (Avizor, Madrid, Spain) and nonpreserved artificial teardrops with 0.3% of hyaluronic acid (Ocudry 0.3%; Avizor, Madrid, Spain) were used. Corneal staining, tear break up time (TBUT), topography, refraction, visual acuity, and subjective comfort and vision with the visual analog scale (score from 0 to 10, being 10 better comfort and vision) were evaluated at 1 day, 1 week, and 1 month of contact lens wear.

Results: The corneal staining was statistically greater in the saline group than in the Ocudry group for the first day and during 1 week of wear (P<0.05). Comfort was found to be statistically better, with Ocudry 0.3% than saline solution, being 7.17±1.94 and 6.37±1.63, for the first day, and 8.78±0.43 and 8.15±0.62 for the day 28, respectively (P<0.05). However, no differences were found for subjective vision scores, TBUT, spherical equivalent, best-corrected visual acuity and uncorrected visual acuity, and mean keratometry between groups for any visit (P>0.05).

Conclusion: Viscous artificial tears improve the subjective comfort of patients and reduce the corneal staining, compared with saline solution during the orthokeratology lenses fitting process. However, no differences between solutions for the treatment efficacy, in vision and corneal topography, were found.

Citing Articles

Lubricating drops for contact lens discomfort in adults.

Caffery B, Pucker A, Chidi-Egboka N, Junior Obinwanne C, Harkness B, Carnt N Cochrane Database Syst Rev. 2024; 9:CD015751.

PMID: 39234924 PMC: 11375780. DOI: 10.1002/14651858.CD015751.pub2.


Sodium hyaluronate promotes proliferation, autophagy, and migration of corneal epithelial cells by downregulating miR-18a in the course of corneal epithelial injury.

Guo Y, Wang H Eur J Histochem. 2023; 67(2).

PMID: 37322995 PMC: 10334306. DOI: 10.4081/ejh.2023.3663.


Functional substitution of zona pellucida with modified sodium hyaluronate gel in human embryos.

Song J, Zhang J, Yuan X, Liu B, Tao W, Zhang C J Assist Reprod Genet. 2022; 39(11):2669-2676.

PMID: 36094700 PMC: 9723041. DOI: 10.1007/s10815-022-02609-7.


Does Orthokeratology Wearing Affect the Tear Quality of Children?.

Tao Z, Wang J, Zhu M, Lin Z, Zhao J, Tang Y Front Pediatr. 2022; 9:773484.

PMID: 35118029 PMC: 8804288. DOI: 10.3389/fped.2021.773484.


Advantages of Hyaluronic Acid and Its Combination with Other Bioactive Ingredients in Cosmeceuticals.

Juncan A, Moisa D, Santini A, Morgovan C, Rus L, Vonica-Tincu A Molecules. 2021; 26(15).

PMID: 34361586 PMC: 8347214. DOI: 10.3390/molecules26154429.


References
1.
Kroenke K, Spitzer R, Williams J . The PHQ-9: validity of a brief depression severity measure. J Gen Intern Med. 2001; 16(9):606-13. PMC: 1495268. DOI: 10.1046/j.1525-1497.2001.016009606.x. View

2.
Rosenthal P, Borsook D . Ocular neuropathic pain. Br J Ophthalmol. 2015; 100(1):128-34. PMC: 4717373. DOI: 10.1136/bjophthalmol-2014-306280. View

3.
Satitpitakul V, Kheirkhah A, Crnej A, Hamrah P, Dana R . Determinants of Ocular Pain Severity in Patients With Dry Eye Disease. Am J Ophthalmol. 2017; 179:198-204. DOI: 10.1016/j.ajo.2017.05.009. View

4.
Woolf C . Evidence for a central component of post-injury pain hypersensitivity. Nature. 1983; 306(5944):686-8. DOI: 10.1038/306686a0. View

5.
Digre K, Brennan K . Shedding light on photophobia. J Neuroophthalmol. 2012; 32(1):68-81. PMC: 3485070. DOI: 10.1097/WNO.0b013e3182474548. View